Global Immunoassays Market 2023-2029
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. According to the latest data, the market size of the global immunoassays sector is expected to rise by USD 11.6 billion with a CAGR of 5.7% by the end of 2029.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global immunoassays market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for immunoassays can be segmented by product: analyzers, reagents & kits, software & services. Among these, the reagents & kits segment was accounted for the highest revenue generator in 2022. Immunoassays market is further segmented by technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA). The LFIA/MIA segment is estimated to account for the largest share of the global immunoassays market. Based on application, the immunoassays market is segmented into: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others. The infectious diseases segment held the largest share of the global immunoassays market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the immunoassays market also can be divided into: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others. In 2022, the hospitals and clinincs segment made up the largest share of revenue generated by the immunoassays market. Immunoassays market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).
Market Segmentation
By product: analyzers, reagents & kits, software & services
By technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)
By application: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others
By end user: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others
By region: Asia Pacific, Europe, North America, Rest of the World (RoW)
The report has also analysed the competitive landscape of the global immunoassays market with some of the key players being Abbott Laboratories, Abcam plc, Becton, Dickinson and Company, bioMerieux, S.A., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, OraSure Technologies, Inc., Ortho Clinical Diagnostics Holdings plc, PerkinElmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global immunoassays market.
To classify and forecast the global immunoassays market based on product, technology, application, end user, region.
To identify drivers and challenges for the global immunoassays market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoassays market.
To identify and analyze the profile of leading players operating in the global immunoassays market.
Why Choose This Report
Gain a reliable outlook of the global immunoassays market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global immunoassays market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for immunoassays can be segmented by product: analyzers, reagents & kits, software & services. Among these, the reagents & kits segment was accounted for the highest revenue generator in 2022. Immunoassays market is further segmented by technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA). The LFIA/MIA segment is estimated to account for the largest share of the global immunoassays market. Based on application, the immunoassays market is segmented into: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others. The infectious diseases segment held the largest share of the global immunoassays market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the immunoassays market also can be divided into: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others. In 2022, the hospitals and clinincs segment made up the largest share of revenue generated by the immunoassays market. Immunoassays market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).
Market Segmentation
By product: analyzers, reagents & kits, software & services
By technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)
By application: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others
By end user: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others
By region: Asia Pacific, Europe, North America, Rest of the World (RoW)
The report has also analysed the competitive landscape of the global immunoassays market with some of the key players being Abbott Laboratories, Abcam plc, Becton, Dickinson and Company, bioMerieux, S.A., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, OraSure Technologies, Inc., Ortho Clinical Diagnostics Holdings plc, PerkinElmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global immunoassays market.
To classify and forecast the global immunoassays market based on product, technology, application, end user, region.
To identify drivers and challenges for the global immunoassays market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoassays market.
To identify and analyze the profile of leading players operating in the global immunoassays market.
Why Choose This Report
Gain a reliable outlook of the global immunoassays market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
TABLE OF CONTENTS
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Analyzers
Reagents & kits
Software & services
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
Enzyme immunoassay (ELISA)
Chemiluminescent immunoassay (CLIA)
Fluorescent immunoassay (FIA)
Radioimmunoassay (RIA)
Lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)
PART 7. MARKET BREAKDOWN BY APPLICATION
Cardiology
Diabetes
Drug screening
Infectious diseases
Oncology
Reproductive
Others
PART 8. MARKET BREAKDOWN BY END USER
Academia
Blood banks
Hospitals and clinincs
Pharmaceutical & biotech companies
Others
PART 9. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 10. KEY COMPANIES
Abbott Laboratories
Abcam plc
Becton, Dickinson and Company
bioMerieux, S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter Inc.)
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Merck & Co., Inc.
Meril Life Sciences Pvt. Ltd.
Mindray Medical International Limited
OraSure Technologies, Inc.
Ortho Clinical Diagnostics Holdings plc
PerkinElmer, Inc.
Quidel Corporation
Randox Laboratories Ltd.
SD Biosensor, Inc.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Analyzers
Reagents & kits
Software & services
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
Enzyme immunoassay (ELISA)
Chemiluminescent immunoassay (CLIA)
Fluorescent immunoassay (FIA)
Radioimmunoassay (RIA)
Lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)
PART 7. MARKET BREAKDOWN BY APPLICATION
Cardiology
Diabetes
Drug screening
Infectious diseases
Oncology
Reproductive
Others
PART 8. MARKET BREAKDOWN BY END USER
Academia
Blood banks
Hospitals and clinincs
Pharmaceutical & biotech companies
Others
PART 9. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 10. KEY COMPANIES
Abbott Laboratories
Abcam plc
Becton, Dickinson and Company
bioMerieux, S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter Inc.)
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Merck & Co., Inc.
Meril Life Sciences Pvt. Ltd.
Mindray Medical International Limited
OraSure Technologies, Inc.
Ortho Clinical Diagnostics Holdings plc
PerkinElmer, Inc.
Quidel Corporation
Randox Laboratories Ltd.
SD Biosensor, Inc.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Multiplex Detection Immunoassays Market Research Report 2021-2025
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Multiplex Detection Immunoassays Report by Material, Application, and Geography Global
USD 2850 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS